tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Argenx price target raised to $942 from $887 at BofA
The FlyArgenx price target raised to $942 from $887 at BofA
1h ago
ARGX
Argenx’s Vyvgart: Strong Performance and Growth Potential Drive Buy Rating
PremiumRatings
Argenx’s Vyvgart: Strong Performance and Growth Potential Drive Buy Rating
2h ago
ARGX
Argenx price target raised to $880 from $800 at Wedbush
PremiumThe Fly
Argenx price target raised to $880 from $800 at Wedbush
7d ago
ARGX
Argenx price target raised to $1,040 from $766 at Morgan Stanley
PremiumThe Fly
Argenx price target raised to $1,040 from $766 at Morgan Stanley
19d ago
ARGX
Vor Bio appoints Khan as Chief Medical Affairs Officer
PremiumThe Fly
Vor Bio appoints Khan as Chief Medical Affairs Officer
27d ago
VOR
ARGX
Argenx price target raised to $882 from $797 at Stifel
PremiumThe FlyArgenx price target raised to $882 from $797 at Stifel
1M ago
ARGX
Argenx’s Strategic Diversification and Promising Pipeline Highlighted by Buy Rating
Premium
Ratings
Argenx’s Strategic Diversification and Promising Pipeline Highlighted by Buy Rating
1M ago
ARGX
Argenx assumed with a Buy at Truist
Premium
The Fly
Argenx assumed with a Buy at Truist
1M ago
ARGX
Argenx downgraded to Hold from Buy at Deutsche Bank
PremiumThe Fly
Argenx downgraded to Hold from Buy at Deutsche Bank
1M ago
ARGX
Deutsche Bank downgrades Argenx to Hold after greater than 40% rally
PremiumThe Fly
Deutsche Bank downgrades Argenx to Hold after greater than 40% rally
1M ago
ARGX
Argenx: A Promising Growth Opportunity with Strategic Expansion and Diversification Beyond Vyvgart
PremiumRatings
Argenx: A Promising Growth Opportunity with Strategic Expansion and Diversification Beyond Vyvgart
2M ago
ARGX
Argenx price target raised to $887 from $880 at BofA
PremiumThe Fly
Argenx price target raised to $887 from $880 at BofA
2M ago
ARGX
Argenx’s Vyvgart Expansion and Pipeline Strength Bolster Buy Rating
PremiumRatingsArgenx’s Vyvgart Expansion and Pipeline Strength Bolster Buy Rating
2M ago
ARGX
Argenx Se’s Vyvgart Gains Momentum with Successful Phase 3 Results and Market Expansion Potential
Premium
Ratings
Argenx Se’s Vyvgart Gains Momentum with Successful Phase 3 Results and Market Expansion Potential
2M ago
ARGX
Argenx price target raised to $808 from $795 at Jefferies
Premium
The Fly
Argenx price target raised to $808 from $795 at Jefferies
2M ago
ARGX
Argenx price target raised to $820 from $750 at Piper Sandler
PremiumThe Fly
Argenx price target raised to $820 from $750 at Piper Sandler
2M ago
ARGX
Argenx’s Vyvgart Shows Promising Phase III Results, Expanding Market Potential for Seronegative gMG Patients
PremiumRatings
Argenx’s Vyvgart Shows Promising Phase III Results, Expanding Market Potential for Seronegative gMG Patients
2M ago
ARGX
Argenx rises 6.0%
PremiumThe Fly
Argenx rises 6.0%
2M ago
ARGX
Figma initiated, Okta upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Figma initiated, Okta upgraded: Wall Street’s top analyst calls
2M ago
S
FN
Argenx announces ADAPT SERON study of Vyvgart met primary endpoint
PremiumThe FlyArgenx announces ADAPT SERON study of Vyvgart met primary endpoint
2M ago
ARGX
Argenx initiated with an Outperform at RBC Capital
Premium
The Fly
Argenx initiated with an Outperform at RBC Capital
2M ago
ARGX
Argenx treatment of idiopathic inflammatory myopathy granted orphan designation
Premium
The Fly
Argenx treatment of idiopathic inflammatory myopathy granted orphan designation
2M ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >